A comprehensive, evidence-based summary of cannabis laws in Tennessee as of October 2026: recreational weed, medical marijuana, penalties, retail, hemp products, and recent legislation.

Psychedelic Alpha flagged a busy “Psychedelics Week” in DC with multiple meetings. Here’s what that activity could signal for policy, access, and the DMV community.

Pennsylvania’s House speaker says legalization is within reach next year if the state Senate shifts—raising big questions about delivery rules, licensing and compliance.

Missouri’s Supreme Court heard a challenge over inconsistent 2019 marijuana license scores. The outcome could reset how states fix flawed scoring—and why delivery licensing needs clearer rules.

A federal health R&D push is exploring ibogaine for opioid use disorder. Here’s what the ARPA-H workshop and ASCENT-IBO call mean for patients and the DMV.

New Cannabis Ventures flags unethical ads for investing using AI. Here’s how cannabis delivery founders and DMV investors can spot red flags and protect themselves.

Resilient resubmits MDMA-assisted therapy to FDA, Definium reports positive oral LSD Phase 3 data in GAD, and Canada funds a C$24M cannabis–brain health consortium.